FLUZONE TRIVALENT NORTHERN HEMISPHERE

🇺🇸 United States

FDA Page

Effective Date: Jul 1, 2026
Approval ID: 53ea81e5-3ac8-4363-e063-6394a90aff2c
Products: 0 registered
Version: 1

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

Fluzone (Influenza Vaccine) injectable suspension, for intramuscular use 2026–2027 Formula Initial U.S. Approval: 1980 These highlights do not include all the information needed to use Fluzone® safely and effectively. See full prescribing information for Fluzone.

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.